Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Baxter
Express Scripts
QuintilesIMS
Cerilliant
Covington
US Army
Moodys
Federal Trade Commission

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075518

« Back to Dashboard
NDA 075518 describes MINOXIDIL EXTRA STRENGTH (FOR MEN), which is a drug marketed by Actavis Mid Atlantic, Avacor Prods, Perrigo New York, Wockhardt, Apotex Inc, and Perrigo, and is included in six NDAs. It is available from twenty-seven suppliers. Additional details are available on the MINOXIDIL EXTRA STRENGTH (FOR MEN) profile page.

The generic ingredient in MINOXIDIL EXTRA STRENGTH (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

Summary for NDA: 075518

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 075518

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MINOXIDIL EXTRA STRENGTH (FOR MEN)
minoxidil
SOLUTION;TOPICAL 075518 ANDA Actavis Mid Atlantic LLC 0472-0094 0472-0094-73 1 BOTTLE in 1 CARTON (0472-0094-73) > 60 mL in 1 BOTTLE
MINOXIDIL EXTRA STRENGTH (FOR MEN)
minoxidil
SOLUTION;TOPICAL 075518 ANDA Actavis Mid Atlantic LLC 0472-0094 0472-0094-75 2 BOTTLE in 1 CARTON (0472-0094-75) > 60 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength5%
Approval Date:Nov 17, 2000TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Teva
Johnson and Johnson
Fish and Richardson
Julphar
McKesson
Accenture
McKinsey
Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot